TY - JOUR
T1 - Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation
AU - Kim, Hangsoo
AU - Mizuno, Masashi
AU - Furuhashi, Kazuhiro
AU - Katsuno, Takayuki
AU - Ozaki, Takenori
AU - Yasuda, Kaoru
AU - Tsuboi, Naotake
AU - Sato, Waichi
AU - Suzuki, Yasuhiro
AU - Matsuo, Seiichi
AU - Ito, Yasuhiko
AU - Maruyama, Shoichi
N1 - Funding Information:
The authors thank T. Mizuno, N. Suzuki, N. Asano, Y. Fujitani and T. Yamada. This work was supported in part by grant-in-aids for Scientific Research from the Ministry of Education, Science , and Culture of Japan ( #21591054 ) and for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan.
PY - 2014/3
Y1 - 2014/3
N2 - Background aims: In patients receiving peritoneal dialysis, fungal or yeast peritonitis has a poor prognosis. In rat peritoneum with mechanical scraping, severe peritonitis can be induced by zymosan, a component of yeast (Zy/scraping peritonitis). Administration of rat adipose tissue-derived stromal cells (ASCs) potentially can improve several tissue injuries. The present study investigated whether rat ASCs could improve peritoneal inflammation in Zy/scraping peritonitis. Methods: Rat ASCs were injected intraperitoneally on a daily basis in rats with Zy/scraping peritonitis. Results: Peritoneal inflammation accompanied by accumulation of inflammatory cells and complement deposition was suppressed by day 5 after injection of rat ASCs. The peritoneal mesothelial layer in Zy/scraping peritonitis with rat ASC treatment was restored compared with the peritoneal mesothelial layer without rat ASC treatment. Injected rat ASCs co-existed with mesothelial cells in the sub-peritoneal layer. In vitro assays showed increased cellular proliferation of rat mesothelial cells combined with rat ASCs by co-culture assays, confirming that fluid factors from rat ASCs might play some role in facilitating the recovery of rat mesothelial cells. Hepatocyte growth factor was released from rat ASCs, and administration of recombinant hepatocyte growth factor increased rat mesothelial cell proliferation. Conclusions: Because the peritoneal mesothelium shows strong expression of membrane complement regulators such as Crry, CD55 and CD59, restoration of the mesothelial cell layer by rat ASCs might prevent deposition of complement activation products and ameliorate peritoneal injuries. This study suggests the therapeutic possibilities of intraperitoneal rat ASC injection to suppress peritoneal inflammation by restoring the mesothelial layer and decreasing complement activation in fungal or yeast peritonitis.
AB - Background aims: In patients receiving peritoneal dialysis, fungal or yeast peritonitis has a poor prognosis. In rat peritoneum with mechanical scraping, severe peritonitis can be induced by zymosan, a component of yeast (Zy/scraping peritonitis). Administration of rat adipose tissue-derived stromal cells (ASCs) potentially can improve several tissue injuries. The present study investigated whether rat ASCs could improve peritoneal inflammation in Zy/scraping peritonitis. Methods: Rat ASCs were injected intraperitoneally on a daily basis in rats with Zy/scraping peritonitis. Results: Peritoneal inflammation accompanied by accumulation of inflammatory cells and complement deposition was suppressed by day 5 after injection of rat ASCs. The peritoneal mesothelial layer in Zy/scraping peritonitis with rat ASC treatment was restored compared with the peritoneal mesothelial layer without rat ASC treatment. Injected rat ASCs co-existed with mesothelial cells in the sub-peritoneal layer. In vitro assays showed increased cellular proliferation of rat mesothelial cells combined with rat ASCs by co-culture assays, confirming that fluid factors from rat ASCs might play some role in facilitating the recovery of rat mesothelial cells. Hepatocyte growth factor was released from rat ASCs, and administration of recombinant hepatocyte growth factor increased rat mesothelial cell proliferation. Conclusions: Because the peritoneal mesothelium shows strong expression of membrane complement regulators such as Crry, CD55 and CD59, restoration of the mesothelial cell layer by rat ASCs might prevent deposition of complement activation products and ameliorate peritoneal injuries. This study suggests the therapeutic possibilities of intraperitoneal rat ASC injection to suppress peritoneal inflammation by restoring the mesothelial layer and decreasing complement activation in fungal or yeast peritonitis.
UR - http://www.scopus.com/inward/record.url?scp=84895082663&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84895082663&partnerID=8YFLogxK
U2 - 10.1016/j.jcyt.2013.10.011
DO - 10.1016/j.jcyt.2013.10.011
M3 - Article
C2 - 24364907
AN - SCOPUS:84895082663
SN - 1465-3249
VL - 16
SP - 357
EP - 368
JO - Cytotherapy
JF - Cytotherapy
IS - 3
ER -
